The Union Cabinet on Wednesday approved the revision of the Livestock Health and Disease Control Programme (LHDCP) with an outlay of ₹3,880 crore for two years.
The scheme aims to enhance the animal health sector through comprehensive vaccination programs, capacity building, disease surveillance, and the strengthening of veterinary infrastructure.
The revised LHDCP consists of three major components:
The programme also includes three sub-components:
A provision of ₹75 crore has been earmarked within the total scheme outlay to ensure access to quality and affordable generic veterinary medicines. These medicines will be distributed through PM-Kisan Samriddhi Kendras and Cooperative Societies, with incentives provided for their sale under the Pashu Aushadhi component.
According to a government press release, livestock productivity is significantly impacted by diseases such as Foot and Mouth Disease (FMD), Brucellosis, Peste des Petits Ruminants (PPR), Cerebrospinal Fluid (CSF), and Lumpy Skin Disease. By implementing systematic vaccination programs, LHDCP aims to curb these diseases and prevent economic losses for farmers.
The scheme supports doorstep livestock healthcare services through Mobile Veterinary Units (ESVHD-MVU) and enhances access to veterinary medicines via Pashu Aushadhi. It will also focus on disease prevention through surveillance and healthcare infrastructure upgrades.
The implementation of LHDCP is expected to improve livestock productivity, generate employment, and encourage entrepreneurship in rural areas. By reducing disease-related losses, the programme will contribute to strengthening the rural economy and supporting farmers dependent on livestock for their livelihood.
With the government’s strong focus on improving livestock health and disease control, the revised LHDCP is set to play a crucial role in ensuring sustainable animal husbandry practices across the country.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.
Published on: Mar 6, 2025, 9:15 AM IST
Dev Sethia
Dev is a content writer with over 2 years of experience at Business Today, Times of India, and Financial Express. He has also contributed stories in Hindi for BT Bazaar and Khalsa Bandhan News Paper. A journalism postgraduate from ACJ-Bloomberg, Dev enjoys spending his spare time on the cricket pitch.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates